Modafinil alone and in combination with low dose amphetamine does not establish conditioned place preference in male Sprague-Dawley rats

Experimental and Clinical Psychopharmacology

Volumn 21, Issue 3, 2013, Pages 252-258

  Quisenberry, Amanda J ^a   Prisinzano, Thomas E ^b   Baker, Lisa E ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Abuse liability; Amphetamine; Conditioned place preference; Drug combinations; Modafinil

Indexed keywords

AMPHETAMINES; ANIMALS; BENZHYDRYL COMPOUNDS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84882614283     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0031832     Document Type: Article

References (38)

1. Anderson, A. L., Reid, M. S., Shou-Hua, L., Holmes, T., Shemanski, L., Slee, A., & Elkashef, A. M. (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence, 104, 133-139. doi:10.1016/j.drugalcdep.2009.04.015
2. Bardo, M. T., Rowlett, J. K., & Harris, M. J. (1995). Conditioned place preference using opiate and stimulant drugs: A meta-analysis. Neuroscience and Biobehavioral Reviews, 19, 39-51. doi:10.1016/0149- 7634(94)00021-R
3. Bernardi, R. E., Lewis, J. R., Lattal, K. M., & Berger, S. P. (2009). Modafinil reinstates a cocaine conditioned place preference following extinction in rats. Behavioural Brain Research, 204, 250-253. doi: 10.1016/j.bbr.2009.05.028
4. Bevins, R. (2005). The references-dose place conditioning procedure yields a graded dose-effect function. International Journal of Comparative Psychology, 18, 101-111.
5. Carstairs, S. D., Urquhart, A., Hoffman, J., Clark, R. F., & Cantrell, F. L. (2010). A retrospective review of supratherapeutic modafinil exposures. Journal of Medical Toxicology, 6, 307-310. doi:10.1007/s13181-010- 0017-6
6. Carter, G. T., Weiss, M. D., Lou, J., Jensen, M. P., Abresch, R. T., Martin, T. K., Hecht, T. W., Han, J. J., Weydt, P., & Kraft, G. H. (2005). Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study. American Journal of Hospice & Palliative Medicine, 22, 55-59. doi:10.1177/104990910502200112
7. Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30, 205- 211. doi:10.1038/sj.npp.1300600
8. De La Garza, R., Zorick, T., London, E. D., & Newton, T. F. (2010). Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence, 106, 173-180. doi:10.1016/ j.drugalcdep.2009.08.013
9. Deroche-Gamonet, V., Darnaudery, M., Bruins-Slot, L., Piat, F., Moal, M. L., & Piazza, P. V. (2002). Study of the addictive potential of modafinil in naïve and cocaine-experienced rats. Psychopharmacology, 161, 387-395. doi:10.1007/s00213-002-1080-8
10. Dopheide, M. M., Morgan, R. E., Rodvelt, K. R., Schachtman, T. R., & Miller, D. K. (2007). Modafinil evokes striatal [3H]dopamine release and alters the subjective properties of stimulants. European Journal of Pharmacology, 568, 112-123. doi:10.1016/j.ejphar.2007.03.044
11. Gold, L. H., & Balster, R. L. (1996). Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology, 126, 286-292. doi:10.1007/BF02247379
12. Hart, C. L., Haney, M., Vosuburg, S. K., Rubin, E., & Foltin, R. W. (2008). Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology, 33, 761-768. doi:10.1038/sj.npp.1301472
13. Heinzerling, K. G., Swanson, A., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010). Randomized, double-blind, placebocontrolled trial of modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 109, 20-29. doi:10.1016/ j.drugalcdep.2009.11.023
14. Hermant, J. F., Rambert, F. A., & Duteil, J. (1991). Awakening properties of modafinil: Effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology, 103, 28- 32. doi:10.1007/BF02244069
15. Högl, B., Saletu, M., Brandauer, E., Glatzi, S., Frauscher, B., Seppi, K., . . . Poewe, W. (2002). Modafinil for the treatment of daytime sleepiness in Parkinson's Disease: A double-blind, randomized, crossover, placebocontrolled polygraphic trial. Sleep, 25, 905-909.
16. Howcroft, D. J., & Jones, R. W. (2005). Does modafinil have the potential to improve disrupted sleep pattern in patients with dementia. International Journal of Geriatric Psychiatry, 20, 492-495. doi:10.1002/gps .1305
17. Keating, G. M., & Raffin, M. J. (2005). Modafinil: A review of its use in excessive sleepiness associated with obstructive sleep apnoea/ hypopnoea syndrome and shift work sleep disorder. CNS Drugs, 19, 785-803.
18. Le Foll, B., & Goldberg, S. R. (2006). Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology, 184, 367- 381. doi:10.1007/s00213-005-0155-8
19. Lin, J. S., Roussel, B., Akaoka, H., Fort, P., Debilly, G., & Jouvet, M. (1992). Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Research, 591, 319-326.
20. Makris, A. P., Rush, C. R., Frederich, R. C., Taylor, A. C., & Kelly, T. H. (2007). Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Experimental and Clinical Psychopharmacology, 15, 123-133. doi:10.1037/1064-1297.15.2.123
21. Malcolm, R., Swayngim, K., Donovan, J. L., DeVane, C. L., Elkashef, A., Chiang, N., . . . Woolson, R. F. (2006). Modafinil and cocaine interactions. The American Journal of Drug and Alcohol Abuse, 32, 577-587. doi:10.1080/00952990600920425
22. Mann, N., & Bitsios, P. (2009). Modafinil treatment of amphetamine abuse in adult ADHD. Journal of Psychopharmacology, 23, 468-471. doi: 10.1177/0269881108091258
23. Minzenberg, M. J., & Carter, C. S. (2008). Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33, 1477-1502.
24. National Research Council of the National Academies. (2011). Guide for the care and use of laboratory animals. Washington, DC: The National Academies Press.
25. Prisinzano, T., Podobinski, J., Tidgewell, K., Luo, M., & Swenson, D. (2004). Synthesis and determination of the absolute configuration of the enantiomers of modafinil. Tetrahedron: Asymmetry, 15, 1053-1058. doi:10.1016/j.tetasy.2004.01.039
26. Reichel, C. M., & See, R. E. (2010). Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology, 210, 337-346. doi:10.1007/s00213-010-1828-5
27. Rush, C. R., Kelly, T. H., Hays, L. R., Baker, R. W., & Wooten, A. F. (2002). Acute behavioral and physiological effects of modafinil in drug abusers. Behavioural Pharmacology, 13, 105-115. doi:10.1097/ 00008877-200203000-00002
28. Shearer, J., Darke, S., Rodgers, C., Slade, T., van Beek, I., Lewis, J., . . . Wodak, A. (2009). A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction, 104, 224- 233. doi:10.1111/j.1360-0443.2008.02437.x
29. Silvestri, A. J., Sanford, L. D., Ross, R. J., Mann, G. L., Pavlock, A., & Morrison, A. R. (2002). The central nucleus of the amygdala and the wake-promoting effects of modafinil. Brain Research, 941, 43-52.
30. Tahsili-Fahadan, P., Carr, G. V., Harris, G. C., & Aston-Jones, G. (2010). Modafinil blocks reinstatement of extinguished opiate-seeking in rats: Mediation by a glutamate mechanism. Neuropsychopharmacology, 35, 2203-2210. doi:10.1038/npp.2010.94
31. Turkington, D., Hedwat, D., Rider, I., & Young, A. H. (2004). Recovery from chronic fatigue syndrome with modafinil. Human Psychopharmacology, 19, 63-64.
32. Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003). Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology, 165, 260-269.
33. Vosburg, S. K., Hart, C. L., Haney, M., Rubin, E., & Foltin, R. W. (2010). Modafinil does not serve as a reinforcer in cocaine abusers. Drug and Alcohol Dependence, 106, 233-236. doi:10.1016/j.drugalcdep.2009.09 .002
34. Warot, D., Corruble, E., Payan, C., Weil, J. S., & Puech, A. J. (1993). Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: A comparison with amphetamine, caffeine, and placebo. European Psychiatry, 8, 201-208.
35. Webb, I. C., Pollock, M. S., & Mistlberger, R. E. (2006). Modafinil [2-[(Diphenylmethyl)sulfinyl]acetamide] and circadian rhythms in Syrian hamsters: Assessment of the chronobiotic potential of a novel alerting compound. The Journal of Pharmacology and Experimental Therapeutics, 317, 882-889. doi:10.1124/jpet.105.099010
36. Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. Dopaminergic role in stimulant-induced wakefulness. The Journal of Neuroscience, 21, 1787-1794.
37. Wuo-Silva, R., Fukushira, D. F., Borcoi, A. R., Fernandes, H. A., Procopio-Souza, R., Hollais, A. W., . . . Frussa-Filho, R. (2011). Addictive potential of modafinil and cross-sensitization with cocaine: A pre-clinical study. Addiction Biology, 16, 565-579. doi:10.1111/j.1369- 1600.2011.00341.x
38. Zolkowska, D., Jain, R., Rothman, R. B., Partilla, J. S., Roth, B. L., Setola, V., . . . Baumann, M. H. (2009). Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. The Journal of Pharmacology and Experimental Therapeutics, 329, 738- 746. doi:10.1124/jpet.108.146142